In 2025, around *** percent of the prescription drug (Rx) market is expected to be at risk due to patent expirations. This corresponds to approximately ** billion U.S. dollars in revenue.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Evaluate. (June 23, 2026). Projected share of global prescription drug revenue at risk from patent expiration from 2018 to 2032 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 07, 2026, from /statistics/309407/global-prescription-drug-revenue-percentage-at-risk-due-to-patent-expiration/
Evaluate. "Projected share of global prescription drug revenue at risk from patent expiration from 2018 to 2032." Chart. June 23, 2026. ÌÇÐÄÆƽâ°æ. Accessed August 07, 2026. /statistics/309407/global-prescription-drug-revenue-percentage-at-risk-due-to-patent-expiration/
Evaluate. (2026). Projected share of global prescription drug revenue at risk from patent expiration from 2018 to 2032. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 07, 2026. /statistics/309407/global-prescription-drug-revenue-percentage-at-risk-due-to-patent-expiration/
Evaluate. "Projected Share of Global Prescription Drug Revenue at Risk from Patent Expiration from 2018 to 2032." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 23 Jun 2026, /statistics/309407/global-prescription-drug-revenue-percentage-at-risk-due-to-patent-expiration/
Evaluate, Projected share of global prescription drug revenue at risk from patent expiration from 2018 to 2032 ÌÇÐÄÆƽâ°æ, /statistics/309407/global-prescription-drug-revenue-percentage-at-risk-due-to-patent-expiration/ (last visited August 07, 2026)
Projected share of global prescription drug revenue at risk from patent expiration from 2018 to 2032 [Graph], Evaluate, June 23, 2026. [Online]. Available: /statistics/309407/global-prescription-drug-revenue-percentage-at-risk-due-to-patent-expiration/
